A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

Abstract Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in this region. This study assessed the...

Full description

Bibliographic Details
Main Authors: Anthony Nuwa, Kevin Baker, Craig Bonnington, Musa Odongo, Tonny Kyagulanyi, John Baptist Bwanika, Sol Richardson, Jane Nabakooza, Jane Achan, Richard Kajubi, David Salandini Odong, Maureen Nakirunda, Godfrey Magumba, Geofrey Beinomugisha, Madeleine Marasciulo-Rice, Hilda Abio, Christian Rassi, Damian Rutazaana, Denis Rubahika, James Tibenderana, Jimmy Opigo
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Malaria Journal
Subjects:
Online Access:https://doi.org/10.1186/s12936-023-04488-4